Literature DB >> 16892053

Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5.

Alex von Kriegsheim1, Andrew Pitt, G Joan Grindlay, Walter Kolch, Amardeep S Dhillon.   

Abstract

The Raf-MEK-ERK pathway couples growth factor, mitogenic and extracellular matrix signals to cell fate decisions such as growth, proliferation, migration, differentiation and survival. Raf-1 is a direct effector of the Ras GTPase and is the initiating kinase in this signalling cascade. Although Raf-1 activation is well studied, little is known about how Raf-1 is inactivated. Here, we used a proteomic approach to identify molecules that may inactivate Raf-1 signalling. Protein phosphatase 5 (PP5) was identified as an inactivator that associates with Raf-1 on growth factor stimulation and selectively dephosphorylates an essential activating site, Ser 338. The PP5-mediated dephosphorylation of Ser 338 inhibited Raf-1 activity and downstream signalling to MEK, an effect that was prevented by phosphomimetic substitution of Ser 338, or by ablation of PP5 catalytic function. Furthermore, depletion of endogenous PP5 increased cellular phospho-Ser 338 levels. Our results suggest that PP5 is a physiological regulator of Raf-1 signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892053     DOI: 10.1038/ncb1465

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  60 in total

Review 1.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

2.  Formation of intracellular concentration landscapes by multisite protein modification.

Authors:  Javier Muñoz-García; Boris N Kholodenko; Zoltán Neufeld
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

Review 3.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

4.  Scaffold proteins confer diverse regulatory properties to protein kinase cascades.

Authors:  Jason W Locasale; Andrey S Shaw; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

Review 5.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

6.  MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1.

Authors:  Zhiguo Liu; Yuguang Liu; Lianling Li; Zhenkuan Xu; Baibin Bi; Yunyan Wang; Jian Yi Li
Journal:  Tumour Biol       Date:  2014-07-16

7.  Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage.

Authors:  Yoonsung Kang; Jung-Hee Lee; Nguyen Ngoc Hoan; Hong-Moon Sohn; In-Youb Chang; Ho Jin You
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

8.  The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy.

Authors:  Xiaofeng Wang; Xiaomin Song; Wei Zhuo; Yan Fu; Hubing Shi; Yun Liang; Maomeng Tong; Guodong Chang; Yongzhang Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

9.  Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.

Authors:  Teresa Golden; Ileana V Aragon; Beth Rutland; J Allan Tucker; Lalita A Shevde; Rajeev S Samant; Guofei Zhou; Lauren Amable; Danalea Skarra; Richard E Honkanen
Journal:  Biochim Biophys Acta       Date:  2008-01-26

10.  A proteomic study of cMyc improvement of CHO culture.

Authors:  Darrin Kuystermans; Michael J Dunn; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2010-03-22       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.